Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $44.83.

OMCL has been the topic of several research reports. JPMorgan Chase & Co. decreased their price target on shares of Omnicell from $44.00 to $36.00 and set a "neutral" rating on the stock in a research note on Thursday, March 20th. Piper Sandler restated an "overweight" rating on shares of Omnicell in a research report on Friday, May 23rd. Wall Street Zen upgraded shares of Omnicell from a "hold" rating to a "buy" rating in a research report on Tuesday, May 20th. Benchmark cut their price target on Omnicell from $62.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Finally, Bank of America increased their price target on Omnicell from $30.00 to $34.00 and gave the stock a "neutral" rating in a research report on Friday, May 23rd.

Omnicell Stock Performance

OMCL stock traded down $0.36 during mid-day trading on Friday, hitting $28.74. 452,399 shares of the company were exchanged, compared to its average volume of 569,003. Omnicell has a 1-year low of $22.66 and a 1-year high of $55.75. The stock has a market capitalization of $1.35 billion, a PE ratio of 62.48 and a beta of 0.78. The business has a 50 day simple moving average of $29.34 and a 200-day simple moving average of $36.12. The company has a current ratio of 1.38, a quick ratio of 1.23 and a debt-to-equity ratio of 0.13.

Omnicell (NASDAQ:OMCL - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.10. Omnicell had a return on equity of 4.60% and a net margin of 1.87%. The business had revenue of $269.67 million during the quarter, compared to analysts' expectations of $260.18 million. During the same period last year, the firm posted $0.03 EPS. The firm's revenue for the quarter was up 9.5% compared to the same quarter last year. On average, equities analysts forecast that Omnicell will post 1.09 earnings per share for the current year.

Institutional Trading of Omnicell

Large investors have recently made changes to their positions in the company. Van ECK Associates Corp lifted its stake in Omnicell by 47.0% during the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company's stock worth $44,000 after purchasing an additional 315 shares during the last quarter. Vontobel Holding Ltd. acquired a new position in shares of Omnicell during the 4th quarter worth $297,000. New York State Teachers Retirement System lifted its position in shares of Omnicell by 2.4% during the 4th quarter. New York State Teachers Retirement System now owns 61,974 shares of the company's stock worth $2,759,000 after buying an additional 1,432 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Omnicell by 4.0% during the 4th quarter. Principal Financial Group Inc. now owns 238,356 shares of the company's stock worth $10,612,000 after buying an additional 9,267 shares during the last quarter. Finally, CIBC Asset Management Inc acquired a new stake in Omnicell in the fourth quarter valued at about $201,000. Institutional investors and hedge funds own 97.70% of the company's stock.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.